Page last updated: 2024-11-04

temozolomide and Brain Damage, Chronic

temozolomide has been researched along with Brain Damage, Chronic in 2 studies

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research Excerpts

ExcerptRelevanceReference
"Radiotherapy (RT) and temozolomide (TMZ) for glioblastoma (GBM) has resulted in longer survival."3.80Employment following chemoradiotherapy in glioblastoma: a prospective case series. ( Back, M; Guo, L; Gzell, C; Kastelan, M; Wheeler, H, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gzell, C1
Wheeler, H1
Guo, L1
Kastelan, M1
Back, M1
Kazda, T1
Pospisil, P1
Vrzal, M1
Sevela, O1
Prochazka, T1
Jancalek, R1
Slampa, P1
Laack, NN1

Other Studies

2 other studies available for temozolomide and Brain Damage, Chronic

ArticleYear
Employment following chemoradiotherapy in glioblastoma: a prospective case series.
    Journal of cancer survivorship : research and practice, 2014, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Brain Damage, Chronic; Brain Neoplasms; Chemoradiotherapy; Combined Modalit

2014
Volumetric modulated arc therapy for hippocampal-sparing radiotherapy in transformed low-grade glioma: A treatment planning case report.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015, Volume: 19, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Damage, Chronic; Cell Dedifferentiation; Combi

2015